All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0459 | Anti-ETV3 (EPR8658) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | EPR8658 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0460 | Anti-ETV3 (ETV3F4D10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | ETV3F4D10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0461 | Anti-ETV3 (CBFYE-1354) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1354 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0462 | Anti-ETV3 (CBFYE-1355) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1355 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0463 | Anti-ETV3 (CBFYE-1356) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1356 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3712 | Anti-ETV3 (EPR8658) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | EPR8658 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3713 | Anti-ETV3 (ETV3F4D10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | ETV3F4D10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3714 | Anti-ETV3 (CBFYE-1354) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1354 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3715 | Anti-ETV3 (CBFYE-1355) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1355 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3716 | Anti-ETV3 (CBFYE-1356) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1356 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION